| 摘要 |
The invention relates to free radical production-inhibitory pharmaceutical compositions containing as active ingredient 3-methyl-7-ethyl-9 alpha -(4-chlorobenzoyloxy)-3,7-diazabicyclo[3,3,1]-nonane prepared in a known manner or a therapeutically acceptable salt thereof together with fillers, diluents and other formulation-promoting additives known in se and commonly used in the preparation of pharmaceutical compositions. Furthermore, the invention relates also to a process for the preparation of these compositions, to their use for the preparation of pharmaceutical compositions having free radical production inhibitory effect and for a method for treating clinical conditions in patients induced by oxidative stress or weakening or exhaustion of the endogenous antioxidant protection of the organism. |
